COVID-19 and the endocrine system: exploring the unexplored
R Pal, M Banerjee - Journal of endocrinological investigation, 2020 - Springer
A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has affected over 2.3 million people, claiming more than …
coronavirus 2 (SARS-CoV-2), has affected over 2.3 million people, claiming more than …
COVID-19 and myositis: what we know so far
Purpose Myositis as a rare manifestation of COVID-19 is only recently being reported. This
review examines the current literature on COVID-19-induced myositis focusing on …
review examines the current literature on COVID-19-induced myositis focusing on …
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
K Khunti, P Knighton, F Zaccardi, C Bakhai… - The lancet Diabetes & …, 2021 - thelancet.com
Background In patients with type 2 diabetes, hyperglycaemia is an independent risk factor
for COVID-19-related mortality. Associations between pre-infection prescription for glucose …
for COVID-19-related mortality. Associations between pre-infection prescription for glucose …
Management of Graves thyroidal and extrathyroidal disease: an update
GJ Kahaly - The Journal of Clinical Endocrinology & Metabolism, 2020 - academic.oup.com
Context Invited update on the management of systemic autoimmune Graves disease (GD)
and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original …
and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original …
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single‐centre, retrospective …
Y Zhang, H Li, J Zhang, Y Cao, X Zhao… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aim To explore whether coronavirus disease 2019 (COVID‐19) patients with diabetes and
secondary hyperglycaemia have different clinical characteristics and prognoses than those …
secondary hyperglycaemia have different clinical characteristics and prognoses than those …
COVID-19 and the endocrine system: a comprehensive review on the theme
G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …
Diabetic ketoacidosis in COVID-19: unique concerns and considerations
NE Palermo, AR Sadhu… - The Journal of Clinical …, 2020 - academic.oup.com
Context While individuals with diabetes appear to be at similar risk for SARS-CoV-2 infection
to those without diabetes, they are more likely to suffer severe consequences, including …
to those without diabetes, they are more likely to suffer severe consequences, including …
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
I Kyrou, E Karteris, T Robbins, K Chatha, F Drenos… - BMC medicine, 2020 - Springer
Background In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes
the most frequent endocrine disorder. Women with PCOS are considered to typically belong …
the most frequent endocrine disorder. Women with PCOS are considered to typically belong …
COVID‐19 pandemic: practical considerations on the organization of an allergy clinic—an EAACI/ARIA Position Paper
Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency
In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …